Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05633511 · ClinicalTrials.gov registry record · NA

Changes of Soft Tissue Grafting: A Randomized Study

A NA study of Gingival Recession, sponsored by Tufts University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05633511 is a NA study of Gingival Recession that is actively recruiting participants, run by Tufts University. The registered enrollment target is 50 participants, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05633511, a NA study of Gingival Recession, is actively recruiting participants, sponsored by Tufts University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

To correct gum recession, patient's own tissue from the roof of the mouth is harvested and placed where there is root exposed. This is considered gold standard of treatment. Sometimes patient don't want to have second surgical site in their mouth and at the same time do not want to use alternative tissue from human or animal donor. Using patients' blood and preparing it as a membrane is the next best thing to correct gum recession.

Conditions Studied

Interventions

  • PROCEDURE Split Mouth Design

Study Locations (1)

Massachusetts

  • Tufts University School of Dental Medicine - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-01-11
Est. Completion 2036-12-30
Phase NA

Sponsor

Tufts University

163 total trials

What the Registry Record Tells You About NCT05633511

The ClinicalTrials.gov registry entry for NCT05633511 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (72% higher). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 1 intervention - of which Split Mouth Design is the first listed.

NCT05633511 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05633511 about?

NCT05633511 is a clinical study titled "Changes of Soft Tissue Grafting: A Randomized Study". To correct gum recession, patient's own tissue from the roof of the mouth is harvested and placed where there is root exposed. This is considered gold standard of treatment. Sometimes patient don't want to have second surgical site in their mouth and at the same time do not want to use alternative t...

What is the current status of trial NCT05633511?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-01-11. Estimated completion is 2036-12-30.

What conditions does trial NCT05633511 study?

This clinical trial studies the following conditions: Gingival Recession.

What interventions are being tested in trial NCT05633511?

The interventions under investigation include: Split Mouth Design (PROCEDURE).

Who is sponsoring clinical trial NCT05633511?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05633511 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingival Recession

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.